The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.

GENEVA, May 20 (Reuters) - China will give an additional $500 million to the World Health Organization over five years, an official told the World Health Assembly on Tuesday, as the U.N.

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...